Dicycloplatin: Difference between revisions

Dicycloplatin
	File:Dicycloplatin02.png
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Newer edit →

Revision as of 11:02, 15 February 2025

A platinum-based chemotherapy drug

Dicycloplatin is a platinum-based chemotherapy drug used in the treatment of various types of cancer. It is a derivative of cisplatin, designed to improve upon the efficacy and reduce the side effects associated with traditional platinum-based therapies.

Chemical structure and properties

Dicycloplatin is a complex of platinum with a unique structure that includes a cyclobutane-1,1-dicarboxylate ligand. This structure is intended to enhance the drug's stability and solubility, making it more effective in targeting cancer cells.

Mechanism of action

Dicycloplatin works by binding to DNA in cancer cells, causing cross-linking that inhibits DNA replication and transcription. This ultimately leads to apoptosis, or programmed cell death, of the cancerous cells. The drug's mechanism is similar to that of other platinum-based drugs, but its unique structure may allow for different cellular uptake and distribution.

Clinical use

Dicycloplatin is used in the treatment of various cancers, including lung cancer, ovarian cancer, and colorectal cancer. It is often administered in combination with other chemotherapeutic agents to enhance its efficacy.

Side effects

As with other platinum-based drugs, dicycloplatin can cause a range of side effects. Common side effects include nausea, vomiting, nephrotoxicity, and myelosuppression. Efforts to reduce these side effects include careful dosing and supportive care measures.

Development and research

Research into dicycloplatin continues, with studies focusing on its effectiveness compared to other platinum-based drugs, its side effect profile, and its potential use in combination therapies. Ongoing clinical trials aim to better understand its role in cancer treatment.

Related pages

@@ Line 1: / Line 1: @@
-'''Dicycloplatin''' is a [[chemotherapy]] agent used in the treatment of various types of [[cancer]]. It is a platinum-based drug, similar to other compounds in its class such as [[cisplatin]] and [[carboplatin]], which are widely used in [[oncology]] for their cytotoxic effects on cancer cells. Dicycloplatin has been studied for its potential benefits in reducing side effects and improving the efficacy of cancer treatment.
+{{Short description|A platinum-based chemotherapy drug}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Dicycloplatin02.png
+| image2 = Dicycloplatin02.png
+}}
-==Mechanism of Action==
+'''Dicycloplatin''' is a [[platinum-based chemotherapy]] drug used in the treatment of various types of [[cancer]]. It is a derivative of [[cisplatin]], designed to improve upon the efficacy and reduce the side effects associated with traditional platinum-based therapies.
-Dicycloplatin works by forming platinum-DNA adducts, which inhibit DNA synthesis and transcription, leading to cell death. This action is similar to that of other platinum-containing drugs, which form cross-links within and between DNA strands, disrupting the cancer cell's ability to replicate and repair its DNA. The unique structure of dicycloplatin allows for a different pharmacokinetic profile, which may contribute to its effectiveness and toxicity profile.
-==Clinical Uses==
+==Chemical structure and properties==
-Dicycloplatin has been investigated for use in various types of cancers, including [[lung cancer]], [[ovarian cancer]], and [[testicular cancer]]. Its role in the treatment regimen may vary depending on the type of cancer, the stage of the disease, and the patient's overall health status. Clinical trials are ongoing to determine the most effective and safe dosages, as well as to compare its efficacy and side effects with those of other platinum-based chemotherapeutic agents.
+Dicycloplatin is a complex of platinum with a unique structure that includes a cyclobutane-1,1-dicarboxylate ligand. This structure is intended to enhance the drug's stability and solubility, making it more effective in targeting cancer cells.
-==Side Effects==
+==Mechanism of action==
-As with other chemotherapy drugs, dicycloplatin can cause a range of side effects. These may include [[nausea]] and [[vomiting]], [[neuropathy]] (nerve damage), [[myelosuppression]] (decreased bone marrow activity), and [[ototoxicity]] (hearing loss). The severity of side effects varies among patients and can often be managed with supportive care and dose adjustments.
+Dicycloplatin works by binding to [[DNA]] in cancer cells, causing cross-linking that inhibits [[DNA replication]] and [[transcription]]. This ultimately leads to [[apoptosis]], or programmed cell death, of the cancerous cells. The drug's mechanism is similar to that of other platinum-based drugs, but its unique structure may allow for different cellular uptake and distribution.
-==Research and Development==
+==Clinical use==
-Research on dicycloplatin is focused on improving the understanding of its mechanism of action, optimizing its use in combination with other therapies, and reducing its side effects. Studies are also exploring the potential for dicycloplatin to overcome resistance to other platinum-based drugs, which is a significant challenge in the treatment of recurrent or refractory cancers.
+Dicycloplatin is used in the treatment of various cancers, including [[lung cancer]], [[ovarian cancer]], and [[colorectal cancer]]. It is often administered in combination with other chemotherapeutic agents to enhance its efficacy.
-==Conclusion==
+==Side effects==
-Dicycloplatin represents a promising addition to the arsenal of chemotherapy agents available for cancer treatment. Its development reflects ongoing efforts to find more effective and tolerable treatments for cancer patients. As research progresses, dicycloplatin may become an important option for oncologists and their patients, offering hope for improved outcomes in the fight against cancer.
+As with other platinum-based drugs, dicycloplatin can cause a range of side effects. Common side effects include [[nausea]], [[vomiting]], [[nephrotoxicity]], and [[myelosuppression]]. Efforts to reduce these side effects include careful dosing and supportive care measures.
-[[Category:Cancer treatment]]
+==Development and research==
-[[Category:Chemotherapy agents]]
+Research into dicycloplatin continues, with studies focusing on its effectiveness compared to other platinum-based drugs, its side effect profile, and its potential use in combination therapies. Ongoing clinical trials aim to better understand its role in cancer treatment.
-[[Category:Platinum compounds]]
-{{Chemotherapy}}
+==Related pages==
-{{Oncology}}
+* [[Cisplatin]]
-{{medicine-stub}}
+* [[Carboplatin]]
+* [[Oxaliplatin]]
+* [[Chemotherapy]]
+* [[Cancer treatment]]
+[[Category:Chemotherapy drugs]]
+[[Category:Platinum-based antineoplastic agents]]